Inventor
LI HAISHAN
US28 patents
⚠️ This page may combine multiple inventors who share the name “LI HAISHAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMERICAN GENE TECH INT INC
27 patentsUS10233464B2Mar 19, 2019
HIV pre-immunization and immunotherapy
AMERICAN GENE TECH INT INC25 citations97
US10036040B2Jul 31, 2018
Methods and compositions for the activation of gamma-delta T-cells
AMERICAN GENE TECH INT INC30 citations97
US10036038B2Jul 31, 2018
HIV pre-immunization and immunotherapy
AMERICAN GENE TECH INT INC25 citations97
US10023880B2Jul 17, 2018
Methods and compositions for the activation of gamma-delta T-cells
AMERICAN GENE TECH INT INC29 citations97
US9914938B2Mar 13, 2018
Methods and compositions for the activation of gamma-delta T-cells
AMERICAN GENE TECH INT INC34 citations97
US9834790B1Dec 5, 2017
Methods and compositions for the activation of gamma-delta T-cells
AMERICAN GENE TECH INT INC33 citations97
US10472649B2Nov 12, 2019
Methods and compositions for the activation of gamma-delta T-cells
AMERICAN GENE TECH INT INC14 citations94
US10137144B2Nov 27, 2018
Methods and compositions for the activation of gamma-delta T-cells
AMERICAN GENE TECH INT INC28 citations94
US10420789B2Sep 24, 2019
Methods and compositions for the activation of gamma-delta T-cells
AMERICAN GENE TECH INT INC13 citations92
US10888613B2Jan 12, 2021
Method of producing cells resistant to HIV infection
AMERICAN GENE TECH INT INC5 citations84
US10772905B2Sep 15, 2020
Methods and compositions for the activation of gamma-delta T-cells
AMERICAN GENE TECH INT INC6 citations84
US10428350B2Oct 1, 2019
Methods and compositions for the activation of gamma-delta T-cells
AMERICAN GENE TECH INT INC7 citations84
US11090379B2Aug 17, 2021
HIV pre-immunization and immunotherapy
AMERICAN GENE TECH INT INC5 citations83
US10767183B2Sep 8, 2020
Combination vectors and methods for treating cancer
AMERICAN GENE TECH INT INC7 citations83
US10494647B2Dec 3, 2019
HIV pre-immunization and immunotherapy
AMERICAN GENE TECH INT INC5 citations83
US11534450B2Dec 27, 2022
Methods and compositions for the activation of gamma-delta T-cells
AMERICAN GENE TECH INT INC1 citations73
US11519006B2Dec 6, 2022
Methods and compositions for the activation of gamma-delta T-cells
AMERICAN GENE TECH INT INC1 citations73
US11612649B2Mar 28, 2023
HIV pre-immunization and immunotherapy
AMERICAN GENE TECH INT INC1 citations72
US11242527B1Feb 8, 2022
Combination vectors and methods for treating cancer
AMERICAN GENE TECH INT INC1 citations72
US11911458B2Feb 27, 2024
HIV pre-immunization and immunotherapy
AMERICAN GENE TECH INT INC1 citations68
US12410446B2Sep 9, 2025
Methods and compositions for the activation of gamma-delta T-cells
AMERICAN GENE TECH INT INC0 citations62
US12403155B2Sep 2, 2025
Methods and compositions for the activation of gamma-delta T-cells
AMERICAN GENE TECH INT INC0 citations62
US12090200B2Sep 17, 2024
Methods of producing cells resistant to HIV infection
AMERICAN GENE TECH INT INC0 citations62
US12559769B2Feb 24, 2026
Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells
AMERICAN GENE TECH INT INC0 citations61
US12359203B2Jul 15, 2025
Combination vectors and methods for treating cancer
AMERICAN GENE TECH INT INC0 citations61
US10975374B2Apr 13, 2021
Combination vectors and methods for treating cancer
AMERICAN GENE TECH INT INC0 citations61
US12370253B2Jul 29, 2025
Pre-immunization and immunotherapy
AMERICAN GENE TECH INT INC0 citations60